Command Palette

Search for a command to run...

SAILIFE
868.2(+0.78%)
1W: +0.09%

Sai Life Sciences Peer Comparison

Snapshot Summary

Sai Life Sciences Ltd. exhibits moderate growth potential but lags behind peers in profitability and valuation metrics. Key competitors such as Cipla and Dr. Reddy's showcase superior profitability, while companies like Divi's Laboratories reveal concerning growth metrics. The sector presents a mix of strong performers and some potential value opportunities, particularly in firms with low PEG ratios but strong margins.

  • Sai Life Sciences Ltd. shows solid revenue growth over three years but struggles in EPS and profitability compared to peers.
  • Cipla and Dr. Reddy's Laboratories are standout performers in terms of profitability metrics.
  • Divi's Laboratories, despite its high PE, is concerning due to its negative revenue growth over three years.
  • Mankind Pharma shows impressive growth and decent profitability, making it a noteworthy contender in the sector.
  • Cipla Ltd.: Leading in profitability with strong ROE and low PE ratio, showcasing excellent financial efficiency.
  • Dr. Reddy's Laboratories Ltd.: Strong overall performance with high margins and solid EPS growth.
  • Mankind Pharma Ltd.: High revenue growth and decent profitability metrics make it a strong contender in the sector.
Stocks
CMP
Market Cap
P/E
ROCE (%)
Debt/Equity
SAILIFE₹845.05₹17,612.03Cr101.7415.53%0.06
SUNPHARMA₹1,563.35₹3,75,099.26Cr87.5917.60%0.04
DIVISLAB₹6,091.05₹1,61,698.50Cr73.2016.46%-
CIPLA₹1,587.60₹1,28,217.27Cr23.7322.77%0.01
TORNTPHARM₹3,581.55₹1,21,215.77Cr61.5324.28%0.57
DRREDDY₹1,280.30₹1,06,835.27Cr15.5026.86%0.07
MANKIND₹2,518.95₹1,03,926.59Cr55.1828.38%0.02

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.